00:06 , Jun 28, 2018 |  BC Extra  |  Company News

Management tracks: Arrakis, Astellas

Arrakis Therapeutics Inc. (Waltham, Mass.) founder and CSO Russ Petter is transitioning to Jennifer Petter. The news was announced in a blog post by Chairman and CEO Michael Gilman. "The support for this transition at...
17:33 , Sep 15, 2017 |  BC Week In Review  |  Company News

ProQR spins out rare disease play Amylon

ProQR Therapeutics N.V. (NASDAQ:PRQR) spun out CNS-focused Amylon Therapeutics B.V. (Leiden, the Netherlands), which simultaneously raised an undisclosed amount in a seed funding from private and institutional investors. ProQR granted Amylon an exclusive license to...
20:50 , Sep 13, 2017 |  BC Extra  |  Company News

ProQR spins out rare disease play Amylon

ProQR Therapeutics N.V. (NASDAQ:PRQR) spun out CNS-focused Amylon Therapeutics B.V. (Leiden, the Netherlands), which simultaneously raised an undisclosed amount in a seed funding from private and institutional investors. ProQR granted Amylon an exclusive license to...
08:00 , Nov 25, 2013 |  BC Week In Review  |  Company News

Aphios neurology, ophthalmic news

Aphios said it will spin off a wholly owned subsidiary, Amylon LLC, to develop and commercialize APH-1104 to treat mild to moderate Alzheimer's disease (AD) and other disorders, such as Down's syndrome, Parkinson's disease (PD)...